NCT04933097Completed
Evaluation of a New Screening Method for Sarcopenia in Rheumatoid Arthritis
Source: ClinicalTrials.gov · Last updated 17 May 2024
Brief summary (registry, in English)
Evaluation of a new screening method for sarcopenia in rheumatoid arthritis
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 164 (actual)
- First submitted
- 11 Jun 2021
- Start date
- 29 Jul 2021
- Primary completion date
- 16 May 2024
- Lead sponsor
- CHU de Reims
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT04933097
What you commit to
- Study type: Interventional
- Participants enrolled: 164
- From 29 Jul 2021 to the primary completion date, 16 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Inability to perform a functional test (walking test)
- Patient under legal protection
- Patients not affiliated to the social security system
- Pregnant women
Who the study is looking for
- Rheumatoid arthritis defined according to ACR/EULAR 2010 criteria,
- Follow-up at the University Hospital of Reims,
- Signed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU Reims Coordinator of this site? Confirm its status | Reims | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.